Companies: 10,795·Total market cap: $144.5T
LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

LMATNASDAQHealthcare● Active
$94.77
+$0.29(+0.31%)
Market Cap$2.2B
P/E Ratio—
52W High$118.01
52W Low$79.01
Free Cash FlowFinancialsRevenue

LeMaitre Vascular, Inc. (LMAT) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

LMAT · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $74.5M for FY2025 (fiscal year ending 2025-12-31), up 100.4% year-over-year The FCF margin was 29.8%. Five-year CAGR stands at +18.5%.

FY2025 Free Cash Flow$74.5M▲ +100.4% YoY
Trailing 12M (TTM)$79.1Mtrailing 4 quarters sum
FCF Margin29.8%$74.5M ÷ revenue
3-Year CAGR+49.8%FY2022 → FY2025
5-Year CAGR+18.5%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
lmat free cash flow history · lmat free cash flow chart · lmat free cash flow growth rate · lmat free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$74.5M▲ +100.4%29.8%
FY2024$37.2M▲ +26.0%16.9%
FY2023$29.5M▲ +33.1%15.2%
FY2022$22.1M▼ 26.7%13.7%
FY2021$30.2M▼ 5.0%19.6%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
lmat free cash flow 2025 · lmat free cash flow 2024 · lmat free cash flow 2023 · lmat operating cash flow

FCF valuation metrics

LeMaitre Vascular, Inc. (LMAT) trades at a FCF yield of 3.65% and a price-to-free-cash-flow ratio of 27.1x. FCF per share stands at $3.50, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
3.65%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$3.50
TTM FCF ÷ Shares Outstanding
Price / FCF
x27.1
Share Price ÷ FCF per Share
EV / FCF (TTM)
x29.4
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
lmat price to free cash flow · lmat free cash flow yield · lmat free cash flow per share · lmat price to cash flow ratio

Cash flow statement summary

For FY2025, LeMaitre Vascular, Inc. generated $81.3M in operating cash flow and spent 7M in capital expenditures, yielding $74.5M in free cash flow.

Operating Activities
+$81.3M
Cash from core business operations
2025-12-31
Investing Activities
−$64.9M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$14.5M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($81.3M) − |CapEx| (7M) = FCF ($74.5M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →
lmat cash flow statement · lmat cash flow statement 2025 · lmat operating cash flow · lmat cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc.YOU
LMAT
$74.5M+100.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

LeMaitre Vascular, Inc. (LMAT) reported free cash flow of $74.5M for FY2025 (fiscal year ending 2025-12-31), up 100.4% year-over-year. The FCF margin was 29.8%.

Based on available data, LeMaitre Vascular, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $74.5M in FY2025. The 5-year CAGR stands at +18.5%.

LeMaitre Vascular, Inc.'s FCF yield is 3.65% and price-to-FCF ratio is 27.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.
RevenueFinancial statementsNet incomeEarningsForecastPrice historyMarket capCash on handP/E ratio

Frequently asked questions

LMAT free cash flow · 8 questions

LeMaitre Vascular, Inc. free cash flow was $74.5M for FY2025, up 100.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $79.1M.

LMAT free cash flowLMAT FCFLMAT FCF 2025LMAT free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · LeMaitre Vascular, Inc. · LeMaitre Vascular, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026